Pyridoxamine
(NHZMQXZHNVQTQA-UHFFFAOYSA-N)
Structure
- SMILES
- NCc1c(CO)cnc(c1O)C
- Type(s)
- Investigational
- Molecular Formula:
- C8H12N2O2
- Molecular Weight:
- 168.193
- Log P:
- 0.7469
- Hydrogen Bond Acceptor:
- 4
- Hydrogen Bond Donor:
- 3
- TPSA:
- 79.37
- CAS Number(s):
- 85-87-0
Synonym(s)
1.
Pyridoxamine
External Link(s)
| MeSH | D011733 |
| PubChem Compound | 11205997 1052 |
| ChEBI | 16410 |
| CHEMBL | CHEMBL593019 |
| DrugBank | DB11673 |
| KEGG | cpd:C00534 |
| Therapeutic Target Database | D02YPU |
| ZINC | 34926229 |
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Acne | FAERS: 1 | US FAERS | |
| 2 | Alopecia | FAERS: 1 | US FAERS | |
| 3 | Asthenia | FAERS: 1 | US FAERS | |
| 4 | Hirsutism | FAERS: 1 | US FAERS | |
| 5 | Muscle hypertrophy | FAERS: 1 | US FAERS | |
| 6 | Albuminuria | 16775596 | CTD | |
| 7 | Cardiomyopathies | 20004697 | CTD | |
| 8 | Dizziness | Canada Vigilance: 1 | Canada Vigilance | |
| 9 | Fatigue | Canada Vigilance: 1 | Canada Vigilance | |
| 10 | Headache | Canada Vigilance: 1 | Canada Vigilance | |
| 11 | Hypercholesterolemia | 19018148 | CTD | |
| 12 | Nausea | Canada Vigilance: 1 | Canada Vigilance | |
| 13 | Rash erythematous | Canada Vigilance: 1 | Canada Vigilance | |
| 14 | Vomiting | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120262
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.